Feature | October 01, 2020| Dave Fornell, Editor

Most Popular Cardiology Technology Content in September 2020

This is the most popular cardiac technology news content from the past month according to reader pageview analytics

The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.

The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.

October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of September 2020. This is based on the website’s 223,889 pageviews for the month. 

1. Abbott Restarts Bioresorbable Stent Clinical Trials With New Esprit Below-the-knee Scaffold

2. Handheld Ultrasound Helps to Monitor COVID-19 Patients With Cardiac Conditions

3. Biosense Webster Carto Prime Mapping Module Offers Tools to Shorten Ablation Time

4. TCT 2020 Late-breaking Study Presentations Announced

5. Medtronic Receives FDA Breakthrough Device Designation and Begins Trial for Intrepid Tricuspid Transcatheter Valve 

6. Boston Scientific Invests in Pulsed Field Ablation Technology To Improve Atrial Fibrillation Therapy

7. Society of Interventional Radiology Publishes IVC Filter Guidelines

8. ECMO Support Found Effective in Sickest of COVID-19 Patients

9. Flexible Electronics Mounted on Balloons May Improve Cardiac Catheter Ablation Procedures 

10. Possible Blood Clotting Mechanism in COVID-19 Found

11. Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

12. Current Evidence for Cardiac CT Calls for Change in Recommendations and Reimbursements

13. FDA Clears TigerEye Image-guided CTO Crossing System

14. Statins May Reduce COVID-19 Severity

15. VIDEO: What to Expect at the Virtual TCT 2020 Meeting — Interview with Juan Granada, M.D.

16. Artificial Intelligence Applications in Cardiology

17. VIDEO: Artificial Intelligence May Improve Cath Lab Interventions — Interview with Nick West, M.D.

18. Recent Developments in Drug-Coated Balloons

19. VIDEO: Interventional Structural Heart Advances Are Rapidly Expanding — Interview with Juan Granada, M.D.

20. VIDEO: Icosapent Ethyl Significantly Reduces Coronary Plaque in EVAPORATE Study — Interview with Matthew Budoff, M.D.

 

Related Popular Cardiology Content: 

Most Popular Cardiology Technology Content in July 2020

Most Popular Cardiology Technology Content in June 2020

Most Popular Cardiology Technology Content in May 2020

Most Popular Cardiology Technology Content in March 2020

Most Popular Cardiology Technology Content in February 2020

Most Popular Cardiology Technology Content in January 2020

Top 25 Cardiology Videos on DAIC in 2019

The Most Popular Cardiology Topics in 2019

Related Content

Ultromics will offer EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.
An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients. #RSNA2020 #RSNA20 #RSNA

An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients.

Feature | Artificial Intelligence | December 02, 2020
December 2, 2020 – Automated deep learning analysis of abdominal...
The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

News | Artificial Intelligence | November 24, 2020
November 24, 2020 — The U.S.
Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS.

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

News | Artificial Intelligence | November 12, 2020
November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd.
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | September 29, 2020 | Joe Fornadel, J.D., and Wes Moran, J.D.
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady
Selfied might be used with AI to identify patients with heart disease. Getty Images

Getty Images

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Sending a photo selfie to the doctor could be a cheap and simple way of detecting heart disease usi
aption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated version of Caption Interpretation, which uses artificial intelligence (AI) to enable clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF) at the point of care.

Caption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated version of Caption Interpretation, which uses artificial intelligence (AI) to enable clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF) at the point of care.

News | Artificial Intelligence | August 19, 2020
August 19, 2020 — Caption Health a leader in medical AI technology, has received U.S.
In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.

In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.

Feature | Artificial Intelligence | August 18, 2020 | Dave Fornell, Editor
The No.